Friedreich's Ataxia Research Alliance (FARA): Phillip Bennett and Kyle Bryant Translational Research Award - LOI

FARA accepts LOIs focusing on pre-clinical and clinical investigations that will advance treatments for FA. The specific aims must target one or more of the following:
* Identification of biomarkers for FA that will elucidate disease variability, severity, and prognosis; facilitate drug screening, and/or optimize selection of patients and clinical endpoints for clinical trials;
* Development of tools and technologies that can (a) be directly used for therapy development; (b) overcome existing obstacles to treatment and (c) be directly applied to, or adapted for, delivery of potential therapeutics;
* Pre-clinical development and testing of potential therapeutics, biologics, and devices in cells and animals;
* Clinical studies of patient outcome measures, potential interventions, or devices.
Funding: $250,000/year for 1 or 2 years.
http://www.curefa.org/types-of-grants.html